AR023657A1 - Composicion, usos de la misma, formulacion farmaceutica, proceso para la preparacion de la composicion y kit - Google Patents

Composicion, usos de la misma, formulacion farmaceutica, proceso para la preparacion de la composicion y kit

Info

Publication number
AR023657A1
AR023657A1 ARP990104627A ARP990104627A AR023657A1 AR 023657 A1 AR023657 A1 AR 023657A1 AR P990104627 A ARP990104627 A AR P990104627A AR P990104627 A ARP990104627 A AR P990104627A AR 023657 A1 AR023657 A1 AR 023657A1
Authority
AR
Argentina
Prior art keywords
composition
preparation
kit
same
pharmaceutical formulation
Prior art date
Application number
ARP990104627A
Other languages
English (en)
Spanish (es)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR023657A1 publication Critical patent/AR023657A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP990104627A 1998-09-16 1999-09-15 Composicion, usos de la misma, formulacion farmaceutica, proceso para la preparacion de la composicion y kit AR023657A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803157A SE9803157D0 (sv) 1998-09-16 1998-09-16 A new composition

Publications (1)

Publication Number Publication Date
AR023657A1 true AR023657A1 (es) 2002-09-04

Family

ID=20412628

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104627A AR023657A1 (es) 1998-09-16 1999-09-15 Composicion, usos de la misma, formulacion farmaceutica, proceso para la preparacion de la composicion y kit

Country Status (21)

Country Link
EP (1) EP1121119A1 (ko)
JP (1) JP2002524509A (ko)
KR (1) KR20010099648A (ko)
CN (1) CN1317963A (ko)
AR (1) AR023657A1 (ko)
AU (1) AU6378199A (ko)
BR (1) BR9913765A (ko)
CA (1) CA2342585A1 (ko)
CZ (1) CZ2001962A3 (ko)
EE (1) EE200100156A (ko)
HU (1) HUP0103569A3 (ko)
ID (1) ID28359A (ko)
IL (1) IL141520A0 (ko)
IS (1) IS5877A (ko)
NO (1) NO20011313L (ko)
PL (1) PL346769A1 (ko)
SE (1) SE9803157D0 (ko)
SK (1) SK3272001A3 (ko)
TR (1) TR200100769T2 (ko)
WO (1) WO2000015219A1 (ko)
ZA (1) ZA200101951B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
DE60122015T2 (de) 2000-10-13 2006-11-23 Neurosearch A/S Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
WO2006123243A2 (en) 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
KR20010099648A (ko) 2001-11-09
TR200100769T2 (tr) 2001-11-21
EE200100156A (et) 2002-08-15
HUP0103569A3 (en) 2002-03-28
SE9803157D0 (sv) 1998-09-16
PL346769A1 (en) 2002-02-25
IS5877A (is) 2001-03-05
CN1317963A (zh) 2001-10-17
AU6378199A (en) 2000-04-03
JP2002524509A (ja) 2002-08-06
ZA200101951B (en) 2002-06-10
NO20011313L (no) 2001-05-16
NO20011313D0 (no) 2001-03-15
ID28359A (id) 2001-05-17
HUP0103569A2 (hu) 2002-02-28
BR9913765A (pt) 2001-06-05
CA2342585A1 (en) 2000-03-23
IL141520A0 (en) 2002-03-10
WO2000015219A1 (en) 2000-03-23
EP1121119A1 (en) 2001-08-08
CZ2001962A3 (cs) 2001-08-15
SK3272001A3 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
SE9501567D0 (sv) A new combination
CA2532859C (en) Use of rotigotine for the treatment of depression
AR015448A1 (es) COMBINACIoN DE UN INHIBIDOR DE REABSORCIoN DE 5-HT CON UN ANTAGONISTA O AGONISTA PARCIAL DE H5-HT1B, PROCESO PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA QUE LA CONTIENE, SU USO PARA PREPARAR MEDICAMENTOS PARA TRATAR TRASTORNOS AFECTIVOS Y KIT QUE CONTIENE DICHA COMBINACIoN
DK2185155T3 (en) PHARMACEUTICAL COMPOSITIONS WITH DOPAMINE RECEPTOR LIGANDS AND TREATMENT METHODS USING DOPAMINE RECEPTOR LIGANDS
KR980000447A (ko) 미르타자핀과 하나 이상의 선택적인 세로토닌 재이용 저해제로 이루어진 약학 조성물
MY125414A (en) Aminopropylphosphinic acids
MXPA05004381A (es) Estereoisomeros de para-hidroxi-milnacipran y metodos de uso de los mismos.
RU97119427A (ru) Сочетание ингибитора усвоения 5-нт с селективным 5-нтia антагонистом
BR0308133A (pt) Forma polimórfica cristalina de cloridrato de irinotecan
KR101408650B1 (ko) 무스카린성 수용체 ｍ1 길항제를 이용한 심리 질환 치료 방법
UY29823A1 (es) Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones
BR9812236A (pt) Combinação de componentes, uso desta, processos para a preparação da mesma, para o tratamento de distúrbios afetivos, para o tratamento de depressão, e para melhorar o inìcio de ação terapêutica, formulação farmacêutica, e, kit
US20120046302A1 (en) Methods of treating cns disorders
CL2009000980A1 (es) Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006).
AR023657A1 (es) Composicion, usos de la misma, formulacion farmaceutica, proceso para la preparacion de la composicion y kit
CR7271A (es) Formulaciones farmaceuticas novedosas a base de melatonina y compuestos similares para su uso en transtornos del sueno
DOP2001000154A (es) Combinación de secretagogos de hormona del crecimiento y antidepresivos
SE9702066D0 (sv) A new salt
SE9804126D0 (sv) New pharmaceutical composition
AR033779A1 (es) Compuestos utiles en la enfermedad de reflujo
CA2731660A1 (en) 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus
BRPI0407529A (pt) uso de r-10-hidróxi-10,11-dihidro-carbamazepina em dor neuropática
AR021808A1 (es) Composicion nueva
BRPI0407569A (pt) uso de s-10-hidróxi-10, 11-diidro-carbamazepina para o tratamento de ansiendade e distúrbios bipolares
AR030145A1 (es) Sal farmaceuticamente aceptable de morfolinobenzamida o solvato de la misma, formulacion farmaceutica que la contiene, su uso para la fabricacion de un medicamento y proceso para la preparacion de dicha sal o solvato